Almost twice as sensitive as TRUS-biopsy for detecting aggressive prostate cancer
The life insurance software vendor has acquired Resonant.
For patients with stage-3 CKD, risk of mortality was higher than for those without CKD, but the risk of progression was low. CKD registers provide an opportunity for GPs to assess the risk of patients developing CVD.
I am aware that you recently admitted to wrongly publishing, as your own, a scientific research paper that I had submitted to Annals of Internal Medicine. After serving as an external peer reviewer on our manuscript, you published that same manuscript in a different medical journal a few months later. You removed the names of the authors and the research site, replacing them with the names of your coauthors and your institution.
The fact that shit like this doesn’t surprise me anymore bothers me.